The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Histone Deacetylases and Mechanisms of Regulation of Gene Expression
Open accessAbstract
In recent years it has become widely recognized that histone modification plays a pivotal role in controlling gene expression and is involved in a wide spectrum of disease regulation. Histone acetylation is a major modification that affects gene transcription and is controlled by histone acetyltransferases (HATs) and histone deacetylases (HDACs). HATs acetylate lysines of histone proteins, resulting in the relaxation of chromatin structure, and they also facilitate gene activation. Conversely, HDACs remove acetyl groups from hyperacetylated histones and suppress general gene transcription. In addition to histones, numerous nonhistone proteins can be acetylated and deacetylated, and they also are involved in the regulation of a wide range of diseases. To date there are 18 HDACs in mammals classified into 4 classes based on homology to yeast HDACs. Accumulating evidence has revealed that HDACs play crucial roles in a variety of biological processes including inflammation, cell proliferation, apoptosis, and carcinogenesis. In this review we summarize the current state of knowledge of HDACs in carcinogenesis and describe the involvement of HDACs in cancer-associated molecular processes. It is hoped than an understanding of the role of HDACs in cancer will lead to the design of more potent and specific drugs targeting selective HDAC proteins for the treatment of the disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Pakala, S. B., Bui-Nguyen, T. M., Reddy, S. D. N., Li, D., Peng, S., Rayala, S. K., Behringer, R. R., & Kumar, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.139469 · Cited by 55
RetractedAnticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919
Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Colotta, F., Allavena, P., Sica, A., Garlanda, C., & Mantovani, A. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp127 · Cited by 2,890
Yoshida, M., Kijima, M., Akita, M., & Beppu, T. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)44885-x · Cited by 1,854
Michishita, E., Park, J. Y., Burneskis, J. M., Barrett, J. C., & Horikawa, I. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-01-0033 · Cited by 1,364
The Rpd3/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men
Yang, X.-J., & Seto, E. (2008) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2346 · Cited by 1,230
Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation
Chen, L.-F., Fischle, W., Verdin, E., & Greene, W. C. (2001) · Science · doi:10.1126/science.1062374 · Cited by 1,222
Marks, P. A., & Breslow, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1272 · Cited by 1,196
Haggarty, S. J., Koeller, K. M., Wong, J. C., Grozinger, C. M., & Schreiber, S. L. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0430973100 · Cited by 1,066
Kelly, W. K., O'Connor, O. A., Krug, L. M., Chiao, J. H., Heaney, M., Curley, T., MacGregore-Cortelli, B., Tong, W., Secrist, J. P., Schwartz, L., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.167 · Cited by 905
Deacetylation of p53 modulates its effect on cell growth and apoptosis
Luo, J., Su, F., Chen, D., Shiloh, A., & Gu, W. (2000) · Nature · doi:10.1038/35042612 · Cited by 818
Class II histone deacetylases: versatile regulators
Verdin, E., Dequiedt, F., & Kasler, H. G. (2003) · Trends in Genetics · doi:10.1016/s0168-9525(03)00073-8 · Cited by 664
Epigenetic interplay between histone modifications and DNA methylation in gene silencing
VAISSIERE, T., SAWAN, C., & HERCEG, Z. (2008) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2008.02.004 · Cited by 636
Wilson, A. J., Byun, D.-S., Popova, N., Murray, L. B., L'Italien, K., Sowa, Y., Arango, D., Velcich, A., Augenlicht, L. H., & Mariadason, J. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510023200 · Cited by 575
Sundaresan, N. R., Samant, S. A., Pillai, V. B., Rajamohan, S. B., & Gupta, M. P. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00426-08 · Cited by 541
Weichert, W., Röske, A., Gekeler, V, Beckers, T., Stephan, C., Jung, K., Fritzsche, F. R., Niesporek, S., Denkert, C., Dietel, M., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604199 · Cited by 477
Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
Tan, J., Cang, S., Ma, Y., Petrillo, R. L., & Liu, D. (2010) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-3-5 · Cited by 425
An Acetylation Site in the Middle Domain of Hsp90 Regulates Chaperone Function
Scroggins, B. T., Robzyk, K., Wang, D., Marcu, M. G., Tsutsumi, S., Beebe, K., Cotter, R. J., Felts, S., Toft, D., Karnitz, L., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.12.008 · Cited by 413
Ryan, Q. C., Headlee, D., Acharya, M., Sparreboom, A., Trepel, J. B., Ye, J., Figg, W. D., Hwang, K., Chung, E. J., Murgo, A., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.188 · Cited by 411
Chen, X., Barozzi, I., Termanini, A., Prosperini, E., Recchiuti, A., Dalli, J., Mietton, F., Matteoli, G., Hiebert, S., & Natoli, G. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1121131109 · Cited by 397
miR-449a targets HDAC-1 and induces growth arrest in prostate cancer
Noonan, E. J., Place, R. F., Pookot, D., Basak, S., Whitson, J. M., Hirata, H., Giardina, C., & Dahiya, R. (2009) · Oncogene · doi:10.1038/onc.2009.19 · Cited by 396
Maintenance of cardiac energy metabolism by histone deacetylase 3 in mice
Montgomery, R. L., Potthoff, M. J., Haberland, M., Qi, X., Matsuzaki, S., Humphries, K. M., Richardson, J. A., Bassel-Duby, R., & Olson, E. N. (2008) · Journal of Clinical Investigation · doi:10.1172/jci35847 · Cited by 362
Vorinostat: a new oral histone deacetylase inhibitor approved for cutaneous T-cell lymphoma
Duvic, M., & Vu, J. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.7.1111 · Cited by 344
Montgomery, R. L., Hsieh, J., Barbosa, A. C., Richardson, J. A., & Olson, E. N. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902750106 · Cited by 306
Rapid changes in histone deacetylases and inflammatory gene expression in expert meditators
Kaliman, P., Álvarez-López, M. J., Cosín-Tomás, M., Rosenkranz, M. A., Lutz, A., & Davidson, R. J. (2014) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2013.11.004 · Cited by 300
Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks
Knutson, S. K., Chyla, B. J., Amann, J. M., Bhaskara, S., Huppert, S. S., & Hiebert, S. W. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.51 · Cited by 271
Müller, B. M., Jana, L., Kasajima, A., Lehmann, A., Prinzler, J., Budczies, J., Winzer, K.-J., Dietel, M., Weichert, W., & Denkert, C. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-215 · Cited by 256
HDAC4 Promotes Growth of Colon Cancer Cells via Repression of p21
Wilson, A. J., Byun, D.-S., Nasser, S., Murray, L. B., Ayyanar, K., Arango, D., Figueroa, M., Melnick, A., Kao, G. D., Augenlicht, L. H., et al. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-02-0139 · Cited by 214
Buurman, R., Gürlevik, E., Schäffer, V., Eilers, M., Sandbothe, M., Kreipe, H., Wilkens, L., Schlegelberger, B., Kühnel, F., & Skawran, B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.05.033 · Cited by 211
Histone deacetylase inhibitors in cancer therapy
Rasheed, W. K., Johnstone, R. W., & Prince, H. M. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.5.659 · Cited by 211
Liu, Y.-L., Yang, P.-M., Shun, C.-T., Wu, M.-S., Weng, J.-R., & Chen, C.-C. (2010) · Autophagy · doi:10.4161/auto.6.8.13365 · Cited by 207
Weichert, W., Denkert, C., Noske, A., Darb-Esfahani, S., Dietel, M., Kalloger, S. E., Huntsman, D. G., & Köbel, M. (2008) · Neoplasia · doi:10.1593/neo.08474 · Cited by 180
Bauer, I., Grozio, A., Lasigliè, D., Basile, G., Sturla, L., Magnone, M., Sociali, G., Soncini, D., Caffa, I., Poggi, A., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.405837 · Cited by 177
HDAC4-Regulated STAT1 Activation Mediates Platinum Resistance in Ovarian Cancer
Stronach, E. A., Alfraidi, A., Rama, N., Datler, C., Studd, J. B., Agarwal, R., Guney, T. G., Gourley, C., Hennessy, B. T., Mills, G. B., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-4111 · Cited by 176
HDAC-mediated deacetylation of NF-κB is critical for Schwann cell myelination
Chen, Y., Wang, H., Yoon, S. O., Xu, X., Hottiger, M. O., Svaren, J., Nave, K. A., Kim, H. A., Olson, E. N., & Lu, Q. R. (2011) · Nature Neuroscience · doi:10.1038/nn.2780 · Cited by 174
Hayashi, A., Horiuchi, A., Kikuchi, N., Hayashi, T., Fuseya, C., 鈴木, 昭., Konishi, I., & Shiozawa, T. (2010) · International Journal of Cancer · doi:10.1002/ijc.25151 · Cited by 173
Pons, D., de Vries, F. R., van den Elsen, P. J., Heijmans, B. T., Quax, P. H. A., & Jukema, J. W. (2008) · European Heart Journal · doi:10.1093/eurheartj/ehn603 · Cited by 168
SIRT1 interacts with p73 and suppresses p73‐dependent transcriptional activity
Dai, J. M., Wang, Z. Y., Sun, D. C., Lin, R. X., & Wang, S. Q. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20831 · Cited by 167
Elsharkawy, A. M., Oakley, F., Lin, F., Packham, G., Mann, D. A., & Mann, J. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2010.03.025 · Cited by 160
The epigenetic mechanism of mechanically induced osteogenic differentiation
Arnsdorf, E. J., Tummala, P., Castillo, A. B., Zhang, F., & Jacobs, C. R. (2010) · Journal of Biomechanics · doi:10.1016/j.jbiomech.2010.07.033 · Cited by 153
Histone deacetylase 1, 2, 6 and acetylated histone H4 in B‐ and T‐cell lymphomas
Marquard, L., Poulsen, C. B., Gjerdrum, L. M. R., Brown, P. D. N., Christensen, I. J., Jensen, P. B., Sehested, M., Johansen, P., & Ralfkiaer, E. M. (2009) · Histopathology · doi:10.1111/j.1365-2559.2009.03290.x · Cited by 144
HDAC3 overexpression and colon cancer cell proliferation and differentiation
Spurling, C. C., Godman, C. A., Noonan, E. J., Rasmussen, T. P., Rosenberg, D. W., & Giardina, C. A. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20373 · Cited by 141
Grausenburger, R., Bilić, I., Boucheron, N., Zupkovitz, G., El-Housseiny, L., Tschismarov, R., Zhang, Y., Rembold, M., Gaisberger, M., Hartl, A. J., et al. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903610 · Cited by 140
A dual role for Hdac1: oncosuppressor in tumorigenesis, oncogene in tumor maintenance
Santoro, F., Botrugno, O. A., Zuffo, R. D., Pallavicini, I., Matthews, G. M., Cluse, L. A., Barozzi, I., Senese, S., Fornasari, L., Moretti, S., et al. (2013) · Blood · doi:10.1182/blood-2012-10-461988 · Cited by 133
Quint, K., Agaimy, A., Fazio, P. D., Montalbano, R., Steindorf, C., Jung, R., Hellerbrand, C., Hartmann, A., Sitter, H., Neureiter, D., et al. (2011) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-011-1103-0 · Cited by 119
Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases
Berger, A., Venturelli, S., Kallnischkies, M., Böcker, A., Busch, C., Weiland, T., Noor, S., Leischner, C., Weiß, T. S., Lauer, U. M., et al. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.07.001 · Cited by 116
HDAC11 is a novel drug target in carcinomas
Deubzer, H. E., Schier, M. C., Oehme, I., Lodrini, M., Haendler, B., Sommer, A., & Witt, O. (2013) · International Journal of Cancer · doi:10.1002/ijc.27876 · Cited by 112
Histone deacetylases: novel targets for prevention of colitis-associated cancer in mice
Glauben, R., Batra, A., Stroh, T., Erben, U., Fedke, I., Lehr, H., Leoni, F., Mascagni, P., Dinarello, C. A., Zeitz, M., et al. (2008) · Gut · doi:10.1136/gut.2007.134650 · Cited by 112
Khabele, D., Son, D., Parl, A. K., Goldberg, G. L., Augenlicht, L. H., Mariadason, J. M., & Rice, V. M. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.5.4007 · Cited by 111
Expression of histone deacetylases 1, 2 and 3 in urothelial bladder cancer
Poyet, C., Jentsch, B., Hermanns, T., Schweckendiek, D., Seifert, H., Schmidtpeter, M., Sulser, T., Moch, H., Wild, P. J., & Kristiansen, G. (2014) · BMC Clinical Pathology · doi:10.1186/1472-6890-14-10 · Cited by 87
Liu, C., Liu, L., Shan, J., Shen, J., Xu, Y., Zhang, Q., Yang, Z., Wu, L., Xia, F., Bie, P., et al. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.07.022 · Cited by 86
Moseley, V. R., Morris, J., Knackstedt, R. W., & Wargovich, M. J. (2013) · PubMed · Cited by 79
Expression profile of histone deacetylases 1, 2 and 3 in ovarian cancer tissues
Jin, K. L., Pak, J. H., Park, J., Choi, W., Lee, J., Kim, J.-H., & Nam, J. (2008) · Journal of Gynecologic Oncology · doi:10.3802/jgo.2008.19.3.185 · Cited by 79
Class I histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma
Adams, H., Fritzsche, F. R., Dirnhofer, S., Kristiansen, G., & Tzankov, A. (2010) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728221003796609 · Cited by 78
Gruhn, B., Naumann, T., Gruner, D., Walther, M., Wittig, S., Becker, S., Beck, J. F., & Sonnemann, J. (2013) · Leukemia Research · doi:10.1016/j.leukres.2013.07.016 · Cited by 73
Epigenetics: differential DNA methylation in mammalian somatic tissues
Nagase, H., & Ghosh, S. (2008) · FEBS Journal · doi:10.1111/j.1742-4658.2008.06330.x · Cited by 71
Anticancer effects of sodium butyrate on hepatocellular carcinoma cells in vitro
Wang, H., Huang, X., Shen, P., Li, L., XUE, H.-T., & Ji, G. (2013) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2013.1285 · Cited by 70
Dong, L., Cheng, S., Zheng, Z., Wang, L., Shen, Y., Shen, Z. X., Chen, S., & Zhao, W. L. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-53 · Cited by 67
Reddy, E. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1014 · Cited by 67
Wang, L., Zou, X., Berger, A. D., Twiss, C. O., Peng, Y., Li, Y., Chiu, J. Y., Guo, H., Satagopan, J. M., Wilton, A. S., et al. (2009) · PubMed · Cited by 54
Chen, H. P., DeNicola, M., Qin, X., Zhao, Y., Zhang, L., Long, X. L., Zhuang, S., Liu, P. Y., & Zhao, T. C. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23251 · Cited by 54
Self-citationHistone deacetylases (HDACs) in XPC gene silencing and bladder cancer
Xu, X., Wang, L., Abrams, J., & Gan, W. (2011) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-4-17 · Cited by 52
Jin, J. S., Tsao, T. Y., Sun, P.-C., Yu, C., & Tzao, C. (2012) · Pathology & Oncology Research · doi:10.1007/s12253-012-9499-7 · Cited by 48
Qu, W., Kang, Y., Zhou, M.-S., Fu, L., Hua, Z., & Wang, L. (2009) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2008.11.018 · Cited by 37
Wilson, A. J., Cheng, Y., & Khabele, D. (2012) · Journal of Ovarian Research · doi:10.1186/1757-2215-5-12 · Cited by 34
E-cadherin gene re-expression in chronic lymphocytic leukemia cells by HDAC inhibitors
Jordaan, G., Liao, W., & Sharma, S. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-88 · Cited by 32
Kwiecińska, P., Wróbel, A. M., Taubøll, E., & Gregoraszczuk, E. Ł. (2013) · Toxicology Letters · doi:10.1016/j.toxlet.2013.10.035 · Cited by 29
Barrasa, J. I., Olmo, N., Santiago-Gómez, A., Lecona, E., Anglard, P., Turnay, J., & Lizarbe, M. A. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2011.12.010 · Cited by 27
Patra, N., De, U., Kim, T. H., Lee, Y. J., Ahn, M. Y., Kim, N. D., Yoon, J. H., Choi, W. S., Moon, H. R., Lee, B. M., et al. (2013) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2013.01.006 · Cited by 25
Kim, S.-O., Choi, B.-T., Choi, I.-W., Cheong, J., Kim, G., Kwon, T. K., Kim, N., & Choi, Y. H. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.10.655 · Cited by 24
Ravillah, D., Mohammed, A., Li, Q., Brewer, M. F., Zhang, Y., Biddick, L., Steele, V. E., & Rao, C. V. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.208645 · Cited by 17
Choi, E.-S., Han, G., Park, S., Lee, K., Kim, H.-J., Cho, S. D., & Kim, H. M. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1481 · Cited by 8
Cited by
Dutta, S., Adhikary, S., Bhattacharya, S., Roy, D., Chatterjee, S., Chakraborty, A., Banerjee, D., Ganguly, A., Nanda, S., & Rajak, P. (2024) · Journal of Environmental Management · doi:10.1016/j.jenvman.2024.120103 · Cited by 796
Opportunities and challenges of radiotherapy for treating cancer
Schaue, D., & McBride, W. H. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.120 · Cited by 784
HDAC inhibitors: A new promising drug class in anti-aging research
Pasyukova, E. G., & Vaiserman, A. M. (2017) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2017.08.008 · Cited by 99
New drugs are not enough‑drug repositioning in oncology: An update
Armando, R., Mengual G�mez, D., & Gomez, D. (2020) · International Journal of Oncology · doi:10.3892/ijo.2020.4966 · Cited by 90
Role of epigenetics in transformation of inflammation into colorectal cancer
Yang, Z.-H., Dang, Y.-Q., & Ji, G. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i23.2863 · Cited by 81
Metadata
- Authors
- Chen, H. P., Zhao, Y. T., & Zhao, T. C.
- Venue
- Critical Reviews in Oncogenesis
- Publisher
- Begell House
- Published
- 2015
- Volume
- 20
- Issue
- 1-2
- Pages
- 35-47
- ISSN
- 0893-9675 (ISSN-L)
- OpenAlex
- W2028391746
- Cited by
- 306
- References
- 72
- FWCI
- 9.26
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.